Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer
- Supplementary File 1:
PDF-Document (PDF, 4800 KiB)
Khandelwal, S.; Boylan, M.; Kirsch, G.; Spallholz, J.E.; Gollahon, L.S. Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer. Antioxidants 2020, 9, 138. https://doi.org/10.3390/antiox9020138
Khandelwal S, Boylan M, Kirsch G, Spallholz JE, Gollahon LS. Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer. Antioxidants. 2020; 9(2):138. https://doi.org/10.3390/antiox9020138
Chicago/Turabian StyleKhandelwal, Soni, Mallory Boylan, Gilbert Kirsch, Julian E. Spallholz, and Lauren S. Gollahon. 2020. "Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer" Antioxidants 9, no. 2: 138. https://doi.org/10.3390/antiox9020138